Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH:ubiquinone oxidoreductase subunit A5 pseudogene 1 (NDUFA5P1) is classified as a pseudogene corresponding to a retrocopy of the functional parental gene NDUFA5, which encodes a subunit of the mitochondrial respiratory chain complex I. As a pseudogene, NDUFA5P1 does not encode a functional protein and is not associated with known biological or disease functions, nor is it a therapeutic target. It is annotated in genomic resources but lacks evidence for clinical or pharmacological relevance[4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit A5 pseudogene 1 (NDUFA5P1).